Larty Research Laboratory, Inc

Artificial Axon Labs Inc is a research and development company based in Topsfield, MA. Specializing in neural technology, the company focuses on creating innovative solutions for brain-computer interfaces. With a team of experts in neuroscience and engineering, Artificial Axon Labs Inc is dedicated to advancing the field of neurotechnology through cutting-edge research and development. Their work aims to enhance communication and interaction between humans and machines. Generated from their business information

The Baim Institute for Clinical Research is a non-profit academic research organization based in Boston, MA. With a global reach, their team collaborates with leading researchers from national and international institutions to design, implement, and complete clinical trials, with a focus on translating the results into clinical practice. Committed to improving health and quality of life, the Baim Institute delivers timely research and innovative solutions that reduce obstacles to implementation and enrollment of clinical trials. Founded in 1993 as the Cardiovascular Data Analysis Center, the Baim Institute has since evolved into a world-class academic environment, formalizing relationships with Harvard Medical School, Partners Healthcare System, and Beth Israel Deaconess Medical Center. With a reputation for excellence, innovation, and collaboration, the Baim Institute offers expertise in a range of therapeutic areas and combines operational capabilities and scientific leadership to maximize the value derived from every research engagement. Their collaborative approach, reputation for quality, independence, and full operational capabilities make them a trusted partner in conducting high-quality clinical research.Generated from the website

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website